---
input_text: Introduction of a ketogenic diet in young infants. The ketogenic diet
  is a rational treatment for pyruvate dehydrogenase complex deficiency (McKusick
  312170) and GLUT1 deficiency syndrome (McKusick 138140). An increasing number of
  patients are diagnosed in early infancy, but few data are available on the introduction
  of a ketogenic diet in this age group. GLUT1 deficiency syndrome was suspected in
  four infants presenting with seizures and unexplained hypoglycorrhachia. A ketogenic
  diet was introduced at 6-28 weeks of age. Ketosis was initiated by fasting, monitored
  by bedside blood glucose and 3-hydroxybutyrate determinations, and was maintained
  successfully using supplemented carbohydrate-free infant formula and emulgated triglycerides.
  All patients developed ketosis within 24 h. 3-Hydroxybutyrate concentrations available
  at the bedside correlated inversely with the base excess. At glucose levels < or
  = 40 mg/dl patients remained asymptomatic in the presence of ketones. The ketogenic
  formula was tolerated well, parental compliance was good, and all patients remained
  seizure-free on the diet. GLUT1 deficiency was confirmed in two patients; the diet
  was discontinued in the other two patients. In one infant, failure to thrive on
  medium-chain triglycerides was effectively reversed using long-chain triglycerides.
  Urine dipstick analyses failed to detect ketosis in another infant. Adverse effects
  of the diet were limited to renal stones in one patient. The ketogenic diet can
  be introduced and maintained successfully in young infants using long-chain fat
  emulsion. Monitoring 3-hydroxybutyrate at the bedside was useful for metabolic control
  and superior to urine dipstick analysis. Seizure control was effective and adverse
  effects were limited, but evaluation of the long-term effects of the ketogenic diet
  in this age group must await ongoing studies.
raw_completion_output: |-
  primary_disease: GLUT1 deficiency syndrome
  medical_actions: Introduction of a ketogenic diet; Fasting to initiate ketosis; Monitoring by bedside blood glucose and 3-hydroxybutyrate determinations; Use of supplemented carbohydrate-free infant formula and emulgated triglycerides; Using long-chain fat emulsion; Urine dipstick analyses
  symptoms: Seizures; Unexplained hypoglycorrhachia; Failure to thrive; Renal stones
  chemicals: 3-Hydroxybutyrate
  action_annotation_relationships: Introduction of a ketogenic diet TREATS seizures IN GLUT1 deficiency syndrome; Fasting to initiate ketosis PREVENTS unexplained hypoglycorrhachia IN GLUT1 deficiency syndrome; Using long-chain fat emulsion TREATS failure to thrive IN GLUT1 deficiency syndrome; Ketogenic diet TREATS renal stones IN GLUT1 deficiency syndrome
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  Ketogenic diet TREATS renal stones IN GLUT1 deficiency syndrome

  ===

extracted_object:
  primary_disease: MONDO:0000188
  medical_actions:
    - Introduction of a ketogenic diet
    - Fasting to initiate ketosis
    - Monitoring by bedside blood glucose and 3-hydroxybutyrate determinations
    - Use of supplemented carbohydrate-free infant formula and emulgated triglycerides
    - Using long-chain fat emulsion
    - Urine dipstick analyses
  symptoms:
    - HP:0001250
    - Unexplained hypoglycorrhachia
    - HP:0001508
    - HP:0000787
  chemicals:
    - CHEBI:37054
  action_annotation_relationships:
    - subject: Introduction of a ketogenic diet
      predicate: TREATS
      object: HP:0001250
      qualifier: MONDO:0000188
      subject_extension: ketogenic diet
    - subject: <Fasting>
      predicate: <PREVENTS>
      object: <hypoglycorrhachia>
      qualifier: <GLUT1 deficiency syndrome>
      subject_qualifier: <to initiate>
      object_qualifier: <unexplained>
      subject_extension: <ketosis>
      object_extension: <unexplained>
    - subject: Using long-chain fat emulsion
      predicate: TREATS
      object: HP:0001508
      qualifier: MONDO:0000188
      subject_extension: long-chain fat emulsion
    - subject: Ketogenic diet
      predicate: TREATS
      object: HP:0000787
      qualifier: MONDO:0000188
      subject_extension: ketogenic diet
named_entities:
  - id: MONDO:0008891
    label: Brown-Vialetto-Van Laere syndrome
  - id: HP:0000407
    label: sensorineural hearing loss
  - id: HP:0002093
    label: respiratory insufficiency
  - id: HP:0007141
    label: sensorimotor neuropathy
  - id: HP:0010871
    label: sensory ataxia
  - id: HP:0000365
    label: hearing loss
  - id: HP:0000648
    label: optic atrophy
  - id: CHEBI:17015
    label: riboflavin
  - id: HP:0012469
    label: infantile spasms
  - id: HP:0000789
    label: infertility
  - id: HP:0005268
    label: miscarriage
  - id: CHEBI:18405
    label: pyridoxal 5'-phosphate
  - id: CHEBI:16709
    label: pyridoxine
  - id: CHEBI:27306
    label: vitamin B6
  - id: CHEBI:24041
    label: flavin mononucleotide
  - id: MONDO:0015540
    label: Familial hemophagocytic lymphohistiocytosis (FHL)
  - id: MAXO:0010030
    label: Bone marrow transplantation
  - id: CHEBI:28901
    label: Busulfan
  - id: CHEBI:4027
    label: Cyclophosphamide
  - id: CHEBI:4911
    label: Etoposide
  - id: MAXO:0000757
    label: Infusion
  - id: MAXO:0000750
    label: Conditioning regimen
  - id: MONDO:0013517
    label: beta-thalassemia
  - id: MONDO:0009666
    label: holocarboxylase synthetase deficiency
  - id: MAXO:0000603
    label: peritoneal dialysis
  - id: HP:0001942
    label: metabolic acidosis
  - id: CHEBI:15956
    label: biotin
  - id: MAXO:0009006
    label: Genome sequencing
  - id: MAXO:0000387
    label: Muscle biopsy
  - id: MAXO:0035059
    label: Nerve conduction studies
  - id: HP:0003701
    label: Proximal muscle weakness
  - id: HP:0002355
    label: Difficulty walking
  - id: HP:0002643
    label: Neonatal respiratory distress
  - id: CHEBI:8665
    label: Pyridostigmine
  - id: HP:0003256
    label: Coagulopathy
  - id: CHEBI:48669
    label: Tranexamic acid
  - id: MAXO:0001298
    label: therapy
  - id: MONDO:0020300
    label: Autosomal dominant nocturnal frontal lobe epilepsy
  - id: CHEBI:3387
    label: Carbamazepine
  - id: HP:0001250
    label: seizures
  - id: MONDO:0000903
    label: Myoclonus-dystonia
  - id: HP:0004308
    label: Ventricular arrhythmias
  - id: HP:0001645
    label: Sudden cardiac death
  - id: MAXO:0000943
    label: Deep brain stimulation
  - id: HP:0001252
    label: hypotonia
  - id: MAXO:0001082
    label: Trabeculectomy
  - id: MAXO:0000960
    label: Viscocanalostomy
  - id: HP:0007906
    label: Increased intraocular pressure
  - id: HP:0000253
    label: Progressive microcephaly
  - id: HP:0001263
    label: Global developmental delay
  - id: HP:0100785
    label: Insomnia
  - id: CHEBI:28892
    label: ganglioside
  - id: HP:0000252
    label: microcephaly
  - id: MAXO:0000950
    label: Supportive care
  - id: CHEBI:8378
    label: prednisolone
  - id: MONDO:0015626
    label: Charcot-Marie-Tooth disease (CMT)
  - id: MAXO:0035087
    label: Peripheral nerve biopsy
  - id: HP:0011096
    label: Demyelination
  - id: HP:0001605
    label: Vocal cord paralysis
  - id: HP:0003477
    label: Axonal neuropathy
  - id: MONDO:0007947
    label: Marfan's syndrome
  - id: HP:0001659
    label: aortic regurgitation
  - id: HP:0002647
    label: aortic dissection
  - id: CHEBI:6541
    label: losartan
  - id: CHEBI:2904
    label: atenolol
  - id: MONDO:0004691
    label: Autosomal dominant polycystic kidney disease (ADPKD)
  - id: HP:0002586
    label: Peritonitis
  - id: HP:0003774
    label: end-stage renal disease
  - id: HP:0100543
    label: cognitive impairment
  - id: HP:0003546
    label: exercise intolerance
  - id: HP:0001251
    label: ataxia
  - id: HP:0001332
    label: dystonia
  - id: HP:0001336
    label: myoclonus
  - id: HP:0001272
    label: cerebellar atrophy
  - id: HP:0002059
    label: cerebral atrophy
  - id: CHEBI:46245
    label: coenzyme Q10 (CoQ10)
  - id: MONDO:0009693
    label: Multiple myeloma
  - id: HP:0002720
    label: IgA deficiency
  - id: MONDO:0011787
    label: Limb-girdle muscular dystrophy type 2I (LGMD2I)
  - id: MONDO:0009662
    label: Sly disease (mucopolysaccharidosis VII)
  - id: HP:0040268
    label: recurrent infections of the middle ears
  - id: HP:0002321
    label: vertigo
  - id: HP:0002719
    label: recurrent infections
  - id: MONDO:0100137
    label: Telomere Diseases
  - id: HP:0005528
    label: Bone marrow failure
  - id: HP:0001394
    label: Liver cirrhosis
  - id: HP:0002206
    label: Pulmonary fibrosis
  - id: HP:0003394
    label: Muscle cramps
  - id: CHEBI:4315
    label: Danazol
  - id: MONDO:0015286
    label: complete DiGeorge syndrome (cDGS)
  - id: MAXO:0010042
    label: thymus transplantation
  - id: HP:0001973
    label: autoimmune thrombocytopenia
  - id: HP:0100646
    label: thyroiditis
  - id: HP:0001873
    label: thrombocytopenia
  - id: HP:0001875
    label: neutropenia
  - id: CHEBI:33281
    label: antimicrobials
  - id: MAXO:0035015
    label: visual acuity assessment
  - id: HP:0032341
    label: reduced Forced Vital Capacity
  - id: HP:0033482
    label: limited shoulder flexion
  - id: HP:0007663
    label: reduced visual acuity
  - id: HP:0012378
    label: fatigue
  - id: MONDO:0010421
    label: X-linked Agammaglobulinemia (XLA)
  - id: MONDO:0005180
    label: Parkinson disease
  - id: MONDO:0007765
    label: Hyperostosis cranialis interna
  - id: MONDO:0018997
    label: Noonan syndrome
  - id: MAXO:0000780
    label: hGH treatment
  - id: HP:0004322
    label: short stature
  - id: MONDO:0015168
    label: Arthrogryposis multiplex congenita
  - id: HP:0002828
    label: Multiple joint contractures
  - id: HP:0001558
    label: Reduced fetal movement
  - id: MONDO:0010518
    label: Wiskott-Aldrich syndrome
  - id: MAXO:0001077
    label: splenectomy
  - id: MONDO:0011724
    label: Glut-1 deficiency syndrome
  - id: HP:0005484
    label: acquired microcephaly
  - id: HP:0001257
    label: spasticity
  - id: HP:0011972
    label: hypoglycorrhachia
  - id: MONDO:0000188
    label: GLUT1 deficiency syndrome
  - id: HP:0001508
    label: Failure to thrive
  - id: HP:0000787
    label: Renal stones
  - id: CHEBI:37054
    label: 3-Hydroxybutyrate
